| Date Filed | Type | Description |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/24/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/14/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/04/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.3% stake in Anavex Life Sciences Corp. |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/07/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 02/07/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.2% stake in ANAVEX LIFE SCIENCES CORP |
| 01/27/2023 |
10-K/A
| Annual Report for the period ended September 30, 2022 [amend] |
| 12/02/2022 |
8-K
| Quarterly results |
| 11/28/2022 |
10-K
| Annual Report for the period ended September 30, 2022 |
| 08/09/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 06/10/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/27/2022 |
8-K
| Quarterly results |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/11/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/11/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/08/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/04/2022 |
8-K
| Quarterly results |
| 02/09/2022 |
SC 13G
| STATE STREET CORP reports a 5% stake in INITIAL FILING ANAVEX LIFE SCIENCES CORP |
| 02/09/2022 |
10-Q
| Quarterly Report for the period ended December 31, 2021 |
| 02/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/04/2022 |
8-K
| Quarterly results |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
8-K
| Investor presentation |
| 11/24/2021 |
10-K
| Annual Report for the period ended September 30, 2021 |
| 09/27/2021 |
8-K
| Quarterly results |
| 09/24/2021 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 09/13/2021 |
8-K
| Quarterly results |
| 08/12/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
|